Your browser doesn't support javascript.
loading
Drug dosing in the critically ill obese patient-a focus on sedation, analgesia, and delirium.
Erstad, Brian L; Barletta, Jeffrey F.
Affiliation
  • Erstad BL; Department of Pharmacy Practice & Science, University of Arizona, College of Pharmacy, 1295 N Martin Ave, PO Box 210202, Tucson, AZ, 85721, USA.
  • Barletta JF; Department of Pharmacy Practice, Midwestern University, College of Pharmacy, 19555 N 59th Ave, Glendale, AZ, 85308, USA. jbarle@midwestern.edu.
Crit Care ; 24(1): 315, 2020 06 08.
Article in En | MEDLINE | ID: mdl-32513237
ABSTRACT
Practice guidelines provide clear evidence-based recommendations for the use of drug therapy to manage pain, agitation, and delirium associated with critical illness. Dosing recommendations however are often based on strategies used in patients with normal body habitus. Recommendations specific to critically ill patients with extreme obesity are lacking. Nonetheless, clinicians must craft dosing regimens for this population. This paper is intended to help clinicians design initial dosing regimens for medications commonly used in the management of pain, agitation, and delirium in critically ill patients with extreme obesity. A detailed literature search was conducted with an emphasis on obesity, pharmacokinetics, and dosing. Relevant manuscripts were reviewed and strategies for dosing are provided.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Delirium / Dose-Response Relationship, Drug / Deep Sedation / Analgesia / Obesity Type of study: Guideline Limits: Humans Language: En Journal: Crit Care Year: 2020 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Delirium / Dose-Response Relationship, Drug / Deep Sedation / Analgesia / Obesity Type of study: Guideline Limits: Humans Language: En Journal: Crit Care Year: 2020 Document type: Article Affiliation country: United States